Medical Xpress news

Medical Xpress / A failed fragile X syndrome drug can reduce cocaine use, clinical trial finds

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use disorder. In their study, ...

Apr 3, 2025 in Medications
Medical Xpress / Powerful new software platform could reshape biomedical research by making data analysis more accessible

A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills.

Apr 3, 2025 in Health informatics
Medical Xpress / Researchers develop nasal spray H5N1 avian influenza vaccine

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus vector-based nasal spray ...

Medical Xpress / A new targeted approach could protect neurons against degeneration

Neurodegenerative conditions such as Parkinson's disease and Alzheimer's involve progressive neuronal loss due to disease-induced damage. An enzyme known as dual leucine-zipper kinase (DLK) plays a key role in this process, ...

Apr 3, 2025 in Neuroscience
Medical Xpress / Novel vaccine concept tackles harmful bacteria in the intestine

The issue of intestinal bacteria is a complex one. On the one hand, people are dependent on the microorganisms because they are the ones that digest the food. On the other hand, there are also numerous pathogens present among ...

Apr 3, 2025 in Vaccination
Medical Xpress / Intestinal immune cell found to prevent food allergies in mice

Most of the time, the intestinal immune system can recognize friend from foe, tolerating myriad foods while destroying disease-causing invaders. But for approximately 30 million Americans with food allergies—including 4 ...

Apr 3, 2025 in Immunology
Medical Xpress / Hitting the target: Imaging reveals psilocybin's neural odyssey

Psilocybin is the active ingredient that gives so-called "magic mushrooms" their hallucinogenic kick. It also has a therapeutic potential for treating depression.

Apr 3, 2025 in Psychology & Psychiatry
Medical Xpress / Beagle study reveals genetic link to face-processing deficits in autism

A new study has revealed that Beagle dogs carrying mutations in the Shank3 gene—a high-risk gene for autism spectrum disorder (ASD)—exhibit face-processing abnormalities similar to those observed in human ASD patients.

Apr 3, 2025 in Genetics
Medical Xpress / Tiny peptide sequence rivals steroid cream in psoriasis treatment

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis when applied topically in an emollient cream.

Apr 3, 2025 in Medical research
Medical Xpress / Ultrasound reveals capillaries and cells in living organs

Researchers from the University of Technology Delft, the Netherlands Institute for Neuroscience and Caltech have developed a microscopy technique based on ultrasound to reveal capillaries and cells across living organs—something ...

Apr 3, 2025 in Radiology & Imaging
Medical Xpress / Parkinson's protein clumps in heart nerves could offer new treatment path

Parkinson's doesn't just affect movement and the brain—it may also impact the heart, according to new research from the University of Surrey. Scientists from Surrey's School of Veterinary Medicine suggest that targeting ...

Apr 3, 2025 in Neuroscience
Medical Xpress / Key differences between visual and memory-led Alzheimer's discovered

Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer's disease, finds a new study by UCL researchers.

Apr 3, 2025 in Neuroscience